Skip to Content

Nanosatellite Carries Drugs into Space

A small satellite launches tonight to test antifungal drugs in orbit.

If you’re on the East Coast, you might be lucky enough to see a United States Air Force rocket sail through the air tonight, between 8:00 and 10:00 P.M. EDT, carrying a tiny satellite into space. Weighing in at a meager 10 pounds, the “nanosatellite,” called PharmSat, was developed by NASA to study how yeast responds to antifungal drugs while in orbit.

Credit: NASA

Past studies have shown that microorganisms can grow more virulent in space, and another nanosatellite mission, GeneSat, launched in 2006 to test how E. coli bacteria behave in space. The goal of such research is to better understand the biological effects of space. (GeneSat was an $8 million project, and its design is the basis for PharmSat.)

The new nanosatellite contains a sensor-studded laboratory that will detect the growth, density, and health of yeast cells receiving three different doses of the antifungal drug over the course of 96 hours. Scientists on the ground will initiate the experiment one hour after liftoff, and data will be sent back to Earth in near real time for up to six months, assuming that no technical glitches or failures occur.

Good luck, PharmSat!

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.